<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000045388">
  <TermName>deferoxamine</TermName>
  <TermPronunciation>(DEH-feh-ROK-suh-meen)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An iron-chelating agent that removes iron from tumors by inhibiting DNA synthesis and causing cancer cell death. It is used in conjunction with other anticancer agents in pediatric neuroblastoma therapy.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000730928" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;deferoxamine&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000730929" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;deferoxamina&quot;" language="es" id="_4"/>
  <SpanishTermName>deferoxamina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia quelante del hierro que extrae el hierro de los tumores al impedir la síntesis del ADN y eliminar las células cancerosas. Se usa junto con otros medicamentos contra el cáncer en el tratamiento del neuroblastoma pediátrico.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
</GlossaryTerm>
